Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	ryanodine-sensitive calcium-release channel activity	RYR2 RYR3	1.12e-04	4	87	2	GO:0005219
GeneOntologyMolecularFunction	calcium-induced calcium release activity	RYR2 RYR3	2.78e-04	6	87	2	GO:0048763
GeneOntologyCellularComponent	laminin-5 complex	LAMA3 LAMA5	1.02e-04	4	87	2	GO:0005610
Domain	ConA-like_dom	CELSR2 SLIT3 TSPEAR LAMA3 LAMA5 TRIM14 NEURL4 RYR2 RYR3	4.96e-07	219	82	9	IPR013320
Domain	EGF	CELSR2 SLIT3 DLK2 LAMA3 LAMA5 NAGPA MEGF11 FBN3 GPR179	8.95e-07	235	82	9	SM00181
Domain	LamG	CELSR2 SLIT3 TSPEAR LAMA3 LAMA5	1.37e-06	44	82	5	SM00282
Domain	Laminin_G	CELSR2 SLIT3 TSPEAR LAMA3 LAMA5	5.50e-06	58	82	5	IPR001791
Domain	hEGF	CELSR2 DLK2 MEGF11 FBN3	6.52e-06	28	82	4	PF12661
Domain	EGF-like_dom	CELSR2 SLIT3 DLK2 LAMA3 LAMA5 NAGPA MEGF11 FBN3	1.36e-05	249	82	8	IPR000742
Domain	EGF_1	CELSR2 SLIT3 DLK2 LAMA3 LAMA5 NAGPA MEGF11 FBN3	1.61e-05	255	82	8	PS00022
Domain	Laminin_EGF	CELSR2 LAMA3 LAMA5 MEGF11	1.63e-05	35	82	4	PF00053
Domain	EGF_Lam	CELSR2 LAMA3 LAMA5 MEGF11	1.63e-05	35	82	4	SM00180
Domain	EGF-like_CS	CELSR2 SLIT3 DLK2 LAMA3 LAMA5 NAGPA MEGF11 FBN3	1.91e-05	261	82	8	IPR013032
Domain	EGF_2	CELSR2 SLIT3 DLK2 LAMA3 LAMA5 NAGPA MEGF11 FBN3	2.13e-05	265	82	8	PS01186
Domain	LAM_G_DOMAIN	CELSR2 SLIT3 LAMA3 LAMA5	2.27e-05	38	82	4	PS50025
Domain	Laminin_EGF	CELSR2 LAMA3 LAMA5 MEGF11	2.27e-05	38	82	4	IPR002049
Domain	Laminin_G_2	CELSR2 SLIT3 LAMA3 LAMA5	2.80e-05	40	82	4	PF02210
Domain	Ryanrecept_TM4-6	RYR2 RYR3	5.70e-05	3	82	2	IPR009460
Domain	RyR	RYR2 RYR3	5.70e-05	3	82	2	PF02026
Domain	Ryanodine_rcpt	RYR2 RYR3	5.70e-05	3	82	2	IPR003032
Domain	RR_TM4-6	RYR2 RYR3	5.70e-05	3	82	2	PF06459
Domain	Ryan_recept	RYR2 RYR3	5.70e-05	3	82	2	IPR013333
Domain	Growth_fac_rcpt_	CELSR2 SLIT3 LAMA3 LAMA5 FBN3 GPR179	6.40e-05	156	82	6	IPR009030
Domain	Laminin_aI	LAMA3 LAMA5	1.89e-04	5	82	2	IPR009254
Domain	Laminin_I	LAMA3 LAMA5	1.89e-04	5	82	2	PF06008
Domain	Laminin_II	LAMA3 LAMA5	1.89e-04	5	82	2	PF06009
Domain	Laminin_domII	LAMA3 LAMA5	1.89e-04	5	82	2	IPR010307
Domain	EGF	CELSR2 SLIT3 DLK2 NAGPA FBN3	2.32e-04	126	82	5	PF00008
Domain	RIH_assoc	RYR2 RYR3	2.82e-04	6	82	2	PF08454
Domain	RIH_assoc-dom	RYR2 RYR3	2.82e-04	6	82	2	IPR013662
Domain	RIH_dom	RYR2 RYR3	2.82e-04	6	82	2	IPR000699
Domain	Ins145_P3_rcpt	RYR2 RYR3	2.82e-04	6	82	2	IPR014821
Domain	Ryanodine_recept-rel	RYR2 RYR3	2.82e-04	6	82	2	IPR015925
Domain	-	RYR2 RYR3	2.82e-04	6	82	2	1.25.10.30
Domain	RYDR_ITPR	RYR2 RYR3	2.82e-04	6	82	2	PF01365
Domain	Ins145_P3_rec	RYR2 RYR3	2.82e-04	6	82	2	PF08709
Domain	EGF_LAM_2	CELSR2 LAMA3 LAMA5	3.04e-04	30	82	3	PS50027
Domain	EGF_LAM_1	CELSR2 LAMA3 LAMA5	3.04e-04	30	82	3	PS01248
Domain	LAMININ_IVA	LAMA3 LAMA5	5.24e-04	8	82	2	PS51115
Domain	Laminin_B	LAMA3 LAMA5	5.24e-04	8	82	2	PF00052
Domain	LamB	LAMA3 LAMA5	5.24e-04	8	82	2	SM00281
Domain	Laminin_IV	LAMA3 LAMA5	5.24e-04	8	82	2	IPR000034
Domain	EGF_3	CELSR2 SLIT3 DLK2 NAGPA MEGF11 FBN3	5.87e-04	235	82	6	PS50026
Domain	-	CELSR2 SLIT3 LAMA3 LAMA5	8.11e-04	95	82	4	2.60.120.200
Domain	MIR	RYR2 RYR3	8.38e-04	10	82	2	PS50919
Domain	MIR	RYR2 RYR3	8.38e-04	10	82	2	PF02815
Domain	MIR	RYR2 RYR3	8.38e-04	10	82	2	SM00472
Domain	MIR_motif	RYR2 RYR3	8.38e-04	10	82	2	IPR016093
Domain	EGF-type_Asp/Asn_hydroxyl_site	CELSR2 SLIT3 DLK2 FBN3	1.22e-03	106	82	4	IPR000152
Domain	Ion_trans_dom	CACNA1F KCNC1 RYR2 RYR3	1.60e-03	114	82	4	IPR005821
Domain	Ion_trans	CACNA1F KCNC1 RYR2 RYR3	1.60e-03	114	82	4	PF00520
Domain	EGF_CA	CELSR2 SLIT3 DLK2 FBN3	2.05e-03	122	82	4	SM00179
Domain	EGF-like_Ca-bd_dom	CELSR2 SLIT3 DLK2 FBN3	2.17e-03	124	82	4	IPR001881
Domain	Laminin_N	LAMA3 LAMA5	2.20e-03	16	82	2	IPR008211
Domain	LAMININ_NTER	LAMA3 LAMA5	2.20e-03	16	82	2	PS51117
Domain	Laminin_N	LAMA3 LAMA5	2.20e-03	16	82	2	PF00055
Domain	LamNT	LAMA3 LAMA5	2.20e-03	16	82	2	SM00136
Domain	EGF_extracell	DLK2 NAGPA MEGF11	2.33e-03	60	82	3	IPR013111
Domain	EGF_2	DLK2 NAGPA MEGF11	2.33e-03	60	82	3	PF07974
Domain	A/G_cyclase_CS	GUCY2F ADCY5	2.48e-03	17	82	2	IPR018297
Domain	Nucleotide_cyclase	GUCY2F ADCY5	2.78e-03	18	82	2	IPR029787
Domain	-	GUCY2F ADCY5	2.78e-03	18	82	2	3.30.70.1230
Domain	GUANYLATE_CYCLASE_1	GUCY2F ADCY5	3.10e-03	19	82	2	PS00452
Domain	Guanylate_cyc	GUCY2F ADCY5	3.10e-03	19	82	2	PF00211
Domain	GUANYLATE_CYCLASE_2	GUCY2F ADCY5	3.10e-03	19	82	2	PS50125
Domain	A/G_cyclase	GUCY2F ADCY5	3.10e-03	19	82	2	IPR001054
Domain	CYCc	GUCY2F ADCY5	3.10e-03	19	82	2	SM00044
Domain	EPHD	KMT2D RAI1	4.15e-03	22	82	2	PS51805
Pubmed	Altered ryanodine receptor expression in mild cognitive impairment and Alzheimer's disease.	RYR2 RYR3	6.48e-06	2	89	2	21531043
Pubmed	Modulation of calcium signalling by dominant negative splice variant of ryanodine receptor subtype 3 in native smooth muscle cells.	RYR2 RYR3	6.48e-06	2	89	2	16678258
Pubmed	In situ-RT-PCR and immunohistochemistry for the localisation of the mRNA of the alpha 3 chain of laminin and laminin-5 during human organogenesis.	LAMA3 LAMA5	6.48e-06	2	89	2	12382139
Pubmed	Biological function of laminin-5 and pathogenic impact of its deficiency.	LAMA3 LAMA5	6.48e-06	2	89	2	17000025
Pubmed	Tissue-specific alternative splicing of mouse brain type ryanodine receptor/calcium release channel mRNA.	RYR2 RYR3	6.48e-06	2	89	2	8898078
Pubmed	The mouse sino-atrial node expresses both the type 2 and type 3 Ca(2+) release channels/ryanodine receptors.	RYR2 RYR3	6.48e-06	2	89	2	14550562
Pubmed	Decreased expression of ryanodine receptors alters calcium-induced calcium release mechanism in mdx duodenal myocytes.	RYR2 RYR3	6.48e-06	2	89	2	14985349
Pubmed	Type 1 and type 3 ryanodine receptors are selectively involved in muscarinic antinociception in mice: an antisense study.	RYR2 RYR3	1.94e-05	3	89	2	18403125
Pubmed	Globular domains 4/5 of the laminin alpha3 chain mediate deposition of precursor laminin 5.	LAMA3 LAMA5	1.94e-05	3	89	2	15316072
Pubmed	Heterogeneous gene expression and functional activity of ryanodine receptors in resistance and conduit pulmonary as well as mesenteric artery smooth muscle cells.	RYR2 RYR3	1.94e-05	3	89	2	18434746
Pubmed	Control of Neuronal Ryanodine Receptor-Mediated Calcium Signaling by Calsenilin.	RYR2 RYR3	1.94e-05	3	89	2	29730765
Pubmed	SPRY domains in ryanodine receptors (Ca(2+)-release channels).	RYR2 RYR3	1.94e-05	3	89	2	9204703
Pubmed	The ryanodine receptor/calcium channel genes are widely and differentially expressed in murine brain and peripheral tissues.	RYR2 RYR3	1.94e-05	3	89	2	7876312
Pubmed	Ryanodine receptors are expressed in epidermal keratinocytes and associated with keratinocyte differentiation and epidermal permeability barrier homeostasis.	RYR2 RYR3	1.94e-05	3	89	2	21881589
Pubmed	Isoform-dependent formation of heteromeric Ca2+ release channels (ryanodine receptors).	RYR2 RYR3	1.94e-05	3	89	2	12213830
Pubmed	Expression of the ryanodine receptor type 3 calcium release channel during development and differentiation of mammalian skeletal muscle cells.	RYR2 RYR3	1.94e-05	3	89	2	9242641
Pubmed	Bidirectional coupling between ryanodine receptors and Ca2+ release-activated Ca2+ (CRAC) channel machinery sustains store-operated Ca2+ entry in human T lymphocytes.	RYR2 RYR3	1.94e-05	3	89	2	22948152
Pubmed	Developmental changes in expression of the three ryanodine receptor mRNAs in the mouse brain.	RYR2 RYR3	1.94e-05	3	89	2	10788707
Pubmed	RYR2 proteins contribute to the formation of Ca(2+) sparks in smooth muscle.	RYR2 RYR3	1.94e-05	3	89	2	15024040
Pubmed	Calcineurin upregulates local Ca(2+) signaling through ryanodine receptor-1 in airway smooth muscle cells.	RYR2 RYR3	1.94e-05	3	89	2	25239916
Pubmed	Ca(2+)-induced Ca2+ release in myocytes from dyspedic mice lacking the type-1 ryanodine receptor.	RYR2 RYR3	1.94e-05	3	89	2	7621815
Pubmed	A gene-specific cerebral types 1, 2, and 3 RyR protein knockdown induces an antidepressant-like effect in mice.	RYR2 RYR3	1.94e-05	3	89	2	18643873
Pubmed	Identification of mutations in the cardiac ryanodine receptor gene in families affected with arrhythmogenic right ventricular cardiomyopathy type 2 (ARVD2).	RYR2 RYR3	1.94e-05	3	89	2	11159936
Pubmed	Molecular identification of the ryanodine receptor pore-forming segment.	RYR2 RYR3	1.94e-05	3	89	2	10473538
Pubmed	Chromosomal localization of murine ryanodine receptor genes RYR1, RYR2, and RYR3 by in situ hybridization.	RYR2 RYR3	1.94e-05	3	89	2	7959768
Pubmed	The organization of proteins in the human red blood cell membrane. A review.	RYR2 RYR3	1.94e-05	3	89	2	4600883
Pubmed	Regulation of mouse egg activation: presence of ryanodine receptors and effects of microinjected ryanodine and cyclic ADP ribose on uninseminated and inseminated eggs.	RYR2 RYR3	1.94e-05	3	89	2	7635066
Pubmed	Localization of laminin-5, HD1/plectin, and BP230 in the submandibular glands of developing and adult mice.	LAMA3 LAMA5	3.87e-05	4	89	2	10651091
Pubmed	A glutathione deficit alters dopamine modulation of L-type calcium channels via D2 and ryanodine receptors in neurons.	RYR2 RYR3	3.87e-05	4	89	2	18206662
Pubmed	Human mast cells adhere to and migrate on epithelial and vascular basement membrane laminins LM-332 and LM-511 via alpha3beta1 integrin.	LAMA3 LAMA5	3.87e-05	4	89	2	19752234
Pubmed	Ryanodine receptor calcium release channels: lessons from structure-function studies.	RYR2 RYR3	3.87e-05	4	89	2	23413940
Pubmed	Membrane type 1 matrix metalloprotease cleaves laminin-10 and promotes prostate cancer cell migration.	LAMA5 MMP14	3.87e-05	4	89	2	15967115
Pubmed	Requirement for the ryanodine receptor type 3 for efficient contraction in neonatal skeletal muscles.	RYR2 RYR3	3.87e-05	4	89	2	9384575
Pubmed	Partial cloning and differential expression of ryanodine receptor/calcium-release channel genes in human tissues including the hippocampus and cerebellum.	RYR2 RYR3	3.87e-05	4	89	2	9607712
Pubmed	Conserved and divergent functions of Nfix in skeletal muscle development during vertebrate evolution.	RYR2 RYR3	3.87e-05	4	89	2	23482488
Pubmed	Expression and distribution of laminin alpha1 and alpha2 chains in embryonic and adult mouse tissues: an immunochemical approach.	LAMA3 LAMA5	6.44e-05	5	89	2	11969289
Pubmed	Sorcin is an early marker of neurodegeneration, Ca2+ dysregulation and endoplasmic reticulum stress associated to neurodegenerative diseases.	RYR2 RYR3	6.44e-05	5	89	2	33060591
Pubmed	Differential expression of five laminin alpha (1-5) chains in developing and adult mouse kidney.	LAMA3 LAMA5	6.44e-05	5	89	2	9415429
Pubmed	Presenilins regulate calcium homeostasis and presynaptic function via ryanodine receptors in hippocampal neurons.	RYR2 RYR3	6.44e-05	5	89	2	23918386
Pubmed	Complete sequence, recombinant analysis and binding to laminins and sulphated ligands of the N-terminal domains of laminin alpha3B and alpha5 chains.	LAMA3 LAMA5	6.44e-05	5	89	2	11829758
Pubmed	Protein kinase C-epsilon regulates local calcium signaling in airway smooth muscle cells.	RYR2 RYR3	6.44e-05	5	89	2	19011160
Pubmed	Differential expression of laminin alpha chains during murine tooth development.	LAMA3 LAMA5	6.44e-05	5	89	2	9389447
Pubmed	Membrane depolarization causes a direct activation of G protein-coupled receptors leading to local Ca2+ release in smooth muscle.	RYR2 RYR3	9.65e-05	6	89	2	19549818
Pubmed	Rectification of muscle and nerve deficits in paralyzed ryanodine receptor type 1 mutant embryos.	RYR2 RYR3	9.65e-05	6	89	2	26025922
Pubmed	Roles of I(f) and intracellular Ca2+ release in spontaneous activity of ventricular cardiomyocytes during murine embryonic development.	RYR2 RYR3	9.65e-05	6	89	2	23463619
Pubmed	HIV-protein-mediated alterations in T cell interactions with the extracellular matrix proteins and endothelium.	LAMA3 LAMA5	9.65e-05	6	89	2	9597096
Pubmed	FKBP12.6 and cADPR regulation of Ca2+ release in smooth muscle cells.	RYR2 RYR3	9.65e-05	6	89	2	14592808
Pubmed	A calcium-induced calcium release mechanism supports luteinizing hormone-induced testosterone secretion in mouse Leydig cells.	RYR2 RYR3	9.65e-05	6	89	2	20519450
Pubmed	Essential Roles of Intracellular Calcium Release Channels in Muscle, Brain, Metabolism, and Aging.	RYR2 RYR3	9.65e-05	6	89	2	25966694
Pubmed	Genotype and phenotype of 101 dutch patients with congenital stationary night blindness.	CACNA1F GPR179	9.65e-05	6	89	2	23714322
Pubmed	HIV-1 Tat activates neuronal ryanodine receptors with rapid induction of the unfolded protein response and mitochondrial hyperpolarization.	RYR2 RYR3	9.65e-05	6	89	2	19009018
Pubmed	IP3Rs are sufficient for dendritic cell Ca2+ signaling in the absence of RyR1.	RYR2 RYR3	9.65e-05	6	89	2	16844763
Pubmed	Maternal Transient Receptor Potential Vanilloid 6 (Trpv6) Is Involved In Offspring Bone Development.	CACNA1F RYR2 RYR3	1.28e-04	38	89	3	30786075
Pubmed	Skeletal and hematological anomalies in HYAL2-deficient mice: a second type of mucopolysaccharidosis IX?	RASSF1 IFRD2	1.35e-04	7	89	2	18772348
Pubmed	Developmental expression of the calcium release channels during early neurogenesis of the mouse cerebral cortex.	RYR2 RYR3	1.35e-04	7	89	2	11860456
Pubmed	Human immunodeficiency virus-1 Tat activates calpain proteases via the ryanodine receptor to enhance surface dopamine transporter levels and increase transporter-specific uptake and Vmax.	RYR2 RYR3	1.35e-04	7	89	2	20962236
Pubmed	Prediction of the coding sequences of unidentified human genes. XX. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro.	NEURL4 MEGF11 FBN3 RAI1	1.69e-04	107	89	4	11347906
Pubmed	Expression and localization of laminin-5 subunits during mouse tooth development.	LAMA3 LAMA5	1.79e-04	8	89	2	9489770
Pubmed	Roles of IP3R and RyR Ca2+ channels in endoplasmic reticulum stress and beta-cell death.	RYR2 RYR3	1.79e-04	8	89	2	19033399
Pubmed	Roles for laminin in embryogenesis: exencephaly, syndactyly, and placentopathy in mice lacking the laminin alpha5 chain.	LAMA3 LAMA5	1.79e-04	8	89	2	9852162
Pubmed	Cloning and expression analyses of mouse dystroglycan gene: specific expression in maternal decidua at the peri-implantation stage.	LAMA3 LAMA5	1.79e-04	8	89	2	8872465
Pubmed	Spatial and temporal control of laminin-332 and -511 expressions during hair morphogenesis.	LAMA3 LAMA5	1.79e-04	8	89	2	23529140
Pubmed	Sequential docking, molecular differentiation, and positioning of T-Tubule/SR junctions in developing mouse skeletal muscle.	RYR2 RYR3	1.79e-04	8	89	2	11784029
Pubmed	The secreted protein discovery initiative (SPDI), a large-scale effort to identify novel human secreted and transmembrane proteins: a bioinformatics assessment.	TMEM25 EEF1AKMT4-ECE2 SEMA5B SLIT3 DLK2 CHRD NXPH4 MEGF11 ALG2 SLC27A3	2.14e-04	985	89	10	12975309
Pubmed	Identification of high-molecular-weight proteins with multiple EGF-like motifs by motif-trap screening.	CELSR2 SLIT3	2.30e-04	9	89	2	9693030
Pubmed	Distribution of the ten known laminin chains in the pathways and targets of developing sensory axons.	LAMA3 LAMA5	2.88e-04	10	89	2	9034910
Pubmed	The Auxiliary Calcium Channel Subunit α2δ4 Is Required for Axonal Elaboration, Synaptic Transmission, and Wiring of Rod Photoreceptors.	CACNA1F GPR179	3.51e-04	11	89	2	28262416
Pubmed	Beta4 integrin is required for hemidesmosome formation, cell adhesion and cell survival.	LAMA3 LAMA5	3.51e-04	11	89	2	8707838
Pubmed	Laminin alpha 5 is required for lobar septation and visceral pleural basement membrane formation in the developing mouse lung.	LAMA3 LAMA5	3.51e-04	11	89	2	12051813
Pubmed	Regional differences in the expression of laminin isoforms during mouse neural tube development.	LAMA3 LAMA5	3.51e-04	11	89	2	21524702
Pubmed	The parvalbumin/somatostatin ratio is increased in Pten mutant mice and by human PTEN ASD alleles.	KCNC1 NPAS1	3.51e-04	11	89	2	25937288
Pubmed	New molecular components supporting ryanodine receptor-mediated Ca(2+) release: roles of junctophilin and TRIC channel in embryonic cardiomyocytes.	RYR2 RYR3	4.20e-04	12	89	2	19095005
Pubmed	Molecular dissection of laminin alpha 5 in vivo reveals separable domain-specific roles in embryonic development and kidney function.	LAMA3 LAMA5	4.20e-04	12	89	2	16750824
Pubmed	Distribution and function of laminins in the neuromuscular system of developing, adult, and mutant mice.	LAMA3 LAMA5	4.20e-04	12	89	2	9396756
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: III. the complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	ZNF512B SEMA5B SLIT3 LAMA5 TNKS1BP1 RAI1 NUAK2	4.26e-04	529	89	7	14621295
Pubmed	BRCA2 mediates centrosome cohesion via an interaction with cytoplasmic dynein.	CFH TERT GPR179	4.29e-04	57	89	3	27433848
Pubmed	Fukutin-related protein alters the deposition of laminin in the eye and brain.	LAMA3 LAMA5	4.96e-04	13	89	2	21900571
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	KMT2D FOXK2 CELSR2 IFRD2 ZBTB4 LAMA5 TNKS1BP1 IDUA MMP14 RAI1	5.28e-04	1105	89	10	35748872
Pubmed	Membrane-type MMPs are indispensable for placental labyrinth formation and development.	LAMA5 MMP14	5.78e-04	14	89	2	20858856
Pubmed	The laminin alpha chains: expression, developmental transitions, and chromosomal locations of alpha1-5, identification of heterotrimeric laminins 8-11, and cloning of a novel alpha3 isoform.	LAMA3 LAMA5	5.78e-04	14	89	2	9151674
Pubmed	Basement membrane composition in the early mouse embryo day 7.	LAMA3 LAMA5	6.65e-04	15	89	2	15895400
Pubmed	AP-2α and AP-2β cooperatively function in the craniofacial surface ectoderm to regulate chromatin and gene expression dynamics during facial development.	NKD1 KREMEN2	6.65e-04	15	89	2	35333176
Pubmed	Localization of basement membrane-associated protein isoforms during development of the ocular surface of mouse eye.	LAMA3 LAMA5	6.65e-04	15	89	2	9264260
Pubmed	The 630-kb lung cancer homozygous deletion region on human chromosome 3p21.3: identification and evaluation of the resident candidate tumor suppressor genes. The International Lung Cancer Chromosome 3p21.3 Tumor Suppressor Gene Consortium.	RASSF1 IFRD2	6.65e-04	15	89	2	11085536
Pubmed	Laminin alpha5 is necessary for submandibular gland epithelial morphogenesis and influences FGFR expression through beta1 integrin signaling.	LAMA3 LAMA5	7.59e-04	16	89	2	17601529
Pubmed	ADAMTS18 Deficiency Affects Neuronal Morphogenesis and Reduces the Levels of Depression-like Behaviors in Mice.	LAMA3 LAMA5	7.59e-04	16	89	2	30579834
Pubmed	TGFβ attenuates cartilage extracellular matrix degradation via enhancing FBXO6-mediated MMP14 ubiquitination.	LAMA3 LAMA5 IDUA MMP14	8.52e-04	164	89	4	32409323
Pubmed	Mouse Nkd1, a Wnt antagonist, exhibits oscillatory gene expression in the PSM under the control of Notch signaling.	NKD1 SLIT3	8.59e-04	17	89	2	15511637
Pubmed	DNA sequence of human chromosome 17 and analysis of rearrangement in the human lineage.	FOXK2 ARHGAP23 GPR179	9.21e-04	74	89	3	16625196
Pubmed	Amplification of extracellular matrix and oncogenes in tat-transfected human salivary gland cell lines with expression of laminin, fibronectin, collagens I, III, IV, c-myc and p53.	LAMA3 LAMA5	9.65e-04	18	89	2	11311202
Pubmed	Laminin and integrin expression in the ventral ectodermal ridge of the mouse embryo: implications for regulation of BMP signalling.	LAMA3 LAMA5	1.19e-03	20	89	2	22911573
Pubmed	Genetic variation in MicroRNA genes and risk of oral premalignant lesions.	MAP3K12 INKA2	1.19e-03	20	89	2	19851984
Pubmed	Resetting the epigenetic balance of Polycomb and COMPASS function at enhancers for cancer therapy.	KMT2D FOXK2	1.19e-03	20	89	2	29785026
Pubmed	Specific 3-O-sulfated heparan sulfate domains regulate salivary gland basement membrane metabolism and epithelial differentiation.	LAMA3 LAMA5 MMP14	1.20e-03	81	89	3	39217171
Pubmed	Congenital heart defect causing mutation in Nkx2.5 displays in vivo functional deficit.	ETV2 RYR2	1.32e-03	21	89	2	28302382
Pubmed	PDGFRβ regulates craniofacial development through homodimers and functional heterodimers with PDGFRα.	LAMA3 LAMA5	1.32e-03	21	89	2	27856617
Pubmed	Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.	ZNF512B CFH USP13 ZBTB4 RIPPLY3 PDCD7 RYR3 ME3 PINK1 ZNF662	1.65e-03	1285	89	10	35914814
Pubmed	Dysregulation of TBX1 dosage in the anterior heart field results in congenital heart disease resembling the 22q11.2 duplication syndrome.	RIPPLY3 ETV2	1.87e-03	25	89	2	29509905
Pubmed	Cannabinoid inhibits HIV-1 Tat-stimulated adhesion of human monocyte-like cells to extracellular matrix proteins.	LAMA3 LAMA5	2.02e-03	26	89	2	24742657
Pubmed	Adamts18 modulates the development of the aortic arch and common carotid artery.	LAMA3 LAMA5	2.02e-03	26	89	2	34189436
GeneFamily	Ryanodine receptors\|Protein phosphatase 1 regulatory subunits	RYR2 RYR3	2.07e-05	3	48	2	287
GeneFamily	Laminin subunits	LAMA3 LAMA5	4.48e-04	12	48	2	626
GeneFamily	Pleckstrin homology domain containing\|Rho guanine nucleotide exchange factors\|C2 domain containing	PLEKHG4B ARHGAP23 ARHGAP12 PLEKHS1	2.15e-03	206	48	4	682
Coexpression	GSE34515_CD16_NEG_VS_POS_MONOCYTE_UP	CACNA1F NKD1 RP1L1 IFRD2 COLCA1 NAGPA SLC27A3	5.50e-06	200	89	7	M8764
Coexpression	DESCARTES_FETAL_LIVER_MESOTHELIAL_CELLS	CPAMD8 NKD1 SLIT3 PNMA8A LAMA3 LAMA5 FBN3 RYR2	1.15e-05	313	89	8	M40228
Coexpression	NABA_ECM_GLYCOPROTEINS	SLIT3 TSPEAR KCP LAMA3 LAMA5 FBN3	5.62e-05	196	89	6	M3008
Coexpression	GSE33374_CD8_ALPHAALPHA_VS_ALPHABETA_CD161_HIGH_TCELL_UP	SEMA5B MAP3K12 NEURL4 RAI1 NPAS1 GGT5	6.11e-05	199	89	6	M8538
Coexpression	HALLMARK_KRAS_SIGNALING_DN	CACNA1F KMT2D CELSR2 DLK2 IDUA RYR2	6.29e-05	200	89	6	M5956
ToppCell	343B-Epithelial_cells-Epithelial-E_(AT2)-\|343B / Donor, Lineage, Cell class and subclass (all cells)	TMEM25 CACNA1F USP13 LAMA3 CHRD LAMA5 FBN3	1.72e-08	145	89	7	80684ec249fa445c1b35f94608a4a6824d53f2d9
ToppCell	343B-Epithelial_cells-Epithelial-E_(AT2)\|343B / Donor, Lineage, Cell class and subclass (all cells)	TMEM25 CACNA1F USP13 LAMA3 CHRD LAMA5 FBN3	1.72e-08	145	89	7	cb534333fba44b241b14fb0d7b74e843f4e7f9f8
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	CFH ADAMTS19 NKD1 ARHGAP23 TSPEAR TMEM200C RYR3	4.76e-08	168	89	7	315ca578c945aeeb77acda2727f3e6db8b43f43e
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	CFH ADAMTS19 NKD1 ARHGAP23 TSPEAR TMEM200C RYR3	7.34e-08	179	89	7	7394e77e665bf16d3733df91bb12907be460ab44
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	CFH ADAMTS19 NKD1 ARHGAP23 TSPEAR TMEM200C RYR3	9.19e-08	185	89	7	b848b63aff4d9dbb9e66a85876d4c7c6dacd0579
ToppCell	facs-Brain_Non-Myeloid-Hippocampus_-18m-Neuronal-neuron\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	AGXT2 ADAMTS19 CHRD MESP2 NXPH4 RYR3	1.08e-06	167	89	6	3dfec2fcc36caa6e394efae5e540a6fa28759977
ToppCell	facs-Brain_Non-Myeloid-Hippocampus_-18m-Neuronal\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	AGXT2 ADAMTS19 CHRD MESP2 NXPH4 RYR3	1.08e-06	167	89	6	95b3b5ba3414729f0460a26a0deca48de0cbe33e
ToppCell	facs-Brain_Non-Myeloid-Hippocampus_-18m-Neuronal-nan\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	AGXT2 ADAMTS19 CHRD MESP2 NXPH4 RYR3	1.08e-06	167	89	6	9480739587d51e67a281778b9bddd7b5ffc3ad92
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ADAMTS19 NKD1 ARHGAP23 TSPEAR TMEM200C RYR3	1.11e-06	168	89	6	fc80e4fecfc92458eb627013a983041d8ca025a9
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ADAMTS19 NKD1 ARHGAP23 TSPEAR TMEM200C RYR3	1.11e-06	168	89	6	e96859dbf51cf8c4def8ee8db132f4d874fb4381
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	CFH ADAMTS19 NKD1 ARHGAP23 TMEM200C RYR3	1.83e-06	183	89	6	848fc6dd129150897ee339343e83c645b6e779eb
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	CFH ADAMTS19 NKD1 TSPEAR TMEM200C RYR3	1.83e-06	183	89	6	7c4b775f351794a3de06bd503eecbc8ae8577c44
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ADAMTS19 NKD1 ARHGAP23 TSPEAR TMEM200C RYR3	1.95e-06	185	89	6	9197f074e769d54031ec41abfc65fcc0c6552c7e
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ADAMTS19 NKD1 ARHGAP23 TSPEAR TMEM200C RYR3	1.95e-06	185	89	6	ce7d62394b09c26ca65b8cdb280afec5e25bbb62
ToppCell	3'-Adult-LargeIntestine-Mesenchymal-Pericytes-Pericyte\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	NKD1 SEMA5B C11orf96 CHRD ADCY5 GGT5	2.08e-06	187	89	6	150023e6a50c9da461f2321074d2d5e96caafb06
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	CFH ARHGAP23 SEMA5B SLIT3 LAMA3 ADCY5	2.14e-06	188	89	6	b21e93a70583c30d05c0833cd3d4d4bca44a039e
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	CFH ARHGAP23 SEMA5B SLIT3 LAMA3 ADCY5	2.14e-06	188	89	6	874404a4fd9aa42873f6c53dc42da22d3b0fdb9e
ToppCell	Parenchymal-10x5prime-Stromal-Myofibroblastic-Muscle_smooth_systemic_arterial\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	SEMA5B C11orf96 SLIT3 CHRD ADCY5 RYR2	2.81e-06	197	89	6	3f078be0b0f5e16edfb6d517beb20ac6178767f0
ToppCell	Bronchial-10x5prime-Stromal-Myofibroblastic-Muscle_perivascular_immune_recruiting\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	CFH C11orf96 SLIT3 ADCY5 RYR2 GGT5	2.89e-06	198	89	6	dc6d9032c5029527e184ac13b887c0c1f22ef1c0
ToppCell	Parenchymal-10x5prime-Stromal-Peri/Epineurial_\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	ZNF512B CFH ADAMTS19 ZNF517 VSIG10L CHRD	3.06e-06	200	89	6	4c3c11dd5e71ebc3d62264eeaeb71a850b149779
ToppCell	Children_(3_yrs)-Epithelial-lung_goblet_cell-D046\|Children_(3_yrs) / Lineage, Cell type, age group and donor	CFH COLCA1 PLEKHS1 VSIG10L2 NXPH4	1.36e-05	152	89	5	1b2a39ae159e79f1fb18d6d164bd7acab5299fca
ToppCell	wk_15-18-Epithelial-Proximal_epithelial-basal_intermediate_\|wk_15-18 / Celltypes from embryonic and fetal-stage human lung	TSPEAR DLK2 LAMA3 SCART1 LRRC74A	1.64e-05	158	89	5	98712ed7e8e65e8c5ff9318cf0e0a04e271a055d
ToppCell	Adult-Mesenchymal-vascular_smooth_muscle_cell-D231\|Adult / Lineage, Cell type, age group and donor	NKD1 SEMA5B SLIT3 ADCY5 RYR2	1.64e-05	158	89	5	8d64c0c9de910a3f4658778642d183c8b9b6f6a2
ToppCell	facs-Lung-Endomucin-24m-Lymphocytic-mature_NK_T_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	AGXT2 KCNC1 CHRD NEURL4 RYR3	1.69e-05	159	89	5	4000ed0d3b7d488722bcd0042fa2ff4405aaab82
ToppCell	facs-Lung-Endomucin-24m-Lymphocytic-Natural_Killer_T_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	AGXT2 KCNC1 CHRD NEURL4 RYR3	1.69e-05	159	89	5	7619d0d49738dd08daf01b42664691a5323aa793
ToppCell	Adult-Mesenchymal-vascular_smooth_muscle_cell-D122\|Adult / Lineage, Cell type, age group and donor	SEMA5B SLIT3 CHRD ADCY5 RYR2	1.74e-05	160	89	5	fd14dfeb7021a4b7299371854dc8fc1fd66c8dae
ToppCell	primary_visual_cortex-Neuronal-glutamatergic_neuron-L6b-L6b_Hsd17b2\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	RP1L1 LRRC74A NXPH4 NUAK2	1.82e-05	78	89	4	e5dbb0986cbee58fb1e5e464a3b003c4136246e7
ToppCell	facs-Lung-24m-Hematologic-lymphocytic-mature_NK_T_cell-mature_NK_T_cell_l22\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	AGXT2 KCNC1 CHRD ALG2 RYR3	2.08e-05	166	89	5	bcdaab49bde5beba750b76fdcc3781a3c12c4fff
ToppCell	facs-Lung-24m-Hematologic-lymphocytic-mature_NK_T_cell\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	AGXT2 KCNC1 CHRD ALG2 RYR3	2.08e-05	166	89	5	5e3b998d740b24f790fad37350d704ca0ea10b77
ToppCell	facs-Trachea-18m-Mesenchymal-fibroblast-fibroblast_of_trachea-tracheal_fibroblast_l15\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	PPP1R3D TRMT44 RP1L1 NXPH4 MEGF11	2.20e-05	168	89	5	a8958b94ffc3423d56c250796dd253884b46f9d9
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	CFH C11orf96 SLIT3 RIPPLY3 GGT5	2.47e-05	172	89	5	1ef243bce63d841c25e4b74d029d1377f84bcc3d
ToppCell	Adult-Mesenchymal-pericyte_cell-D231\|Adult / Lineage, Cell type, age group and donor	SEMA5B SLIT3 KCP ADCY5 RYR2	2.47e-05	172	89	5	858cee96c1c06160863b4adcd7023c0d678bd50f
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	CFH ADAMTS19 ARHGAP23 TMEM200C RYR3	2.47e-05	172	89	5	6c17a1e586a72d1bd80c20c06370429c61dc9f85
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	CFH C11orf96 SLIT3 RIPPLY3 GGT5	2.47e-05	172	89	5	ab1c81be29f93ca8920c6ab5ab92f497a9256d3f
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ADAMTS19 NKD1 TSPEAR TMEM200C RYR3	2.47e-05	172	89	5	381ae1c3c07d0a424f43455ec571653b192a946a
ToppCell	Adult-Epithelial-club_cell-D175\|Adult / Lineage, Cell type, age group and donor	CFH PLEKHG4B CPAMD8 RAI1 GGT5	2.83e-05	177	89	5	d652b7d84fe6aa38319d8d5adc72c70441bd0088
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	ADAMTS19 NKD1 TSPEAR TMEM200C RYR3	2.83e-05	177	89	5	4d2cdb57b427a42085c5f9affa0967b15e84dec3
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	ADAMTS19 NKD1 TSPEAR TMEM200C RYR3	2.91e-05	178	89	5	edc7143dc9959d36057cb9471681a23afcbc8cce
ToppCell	facs-Lung-nan-3m-Mesenchymal-Pericyte\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TNKS1BP1 ADCY5 NXPH4 INKA2 GPR179	2.99e-05	179	89	5	7078022e60faa86444f2a2c6eb9f767cc66b5cfa
ToppCell	facs-Lung-nan-3m-Mesenchymal-pericyte_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TNKS1BP1 ADCY5 NXPH4 INKA2 GPR179	2.99e-05	179	89	5	d4a975d8ffa5e77fb5c0ec05bf9c8f843c77ce07
ToppCell	droplet-Heart-nan-24m-Mesenchymal-smooth_muscle_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	C11orf96 PLEKHS1 TNKS1BP1 ADCY5 NXPH4	3.07e-05	180	89	5	78fdcfb3fdbf36469cae78407cda5bd0996930d8
ToppCell	Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)\|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	CFH ADAMTS19 ARHGAP12 SLIT3 RYR3	3.07e-05	180	89	5	e8841ef1239f9ee73ac4f4e11faca0742694f368
ToppCell	kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	CFH NKD1 C11orf96 SLIT3 GGT5	3.15e-05	181	89	5	c6d2a13df3b74fade3b0c71e285b4c14c8e52413
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	ADAMTS19 NKD1 TSPEAR TMEM200C RYR3	3.15e-05	181	89	5	5bf7aa43f6e6ecce15c95928b91195544d6928c4
ToppCell	kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	CFH NKD1 C11orf96 SLIT3 GGT5	3.15e-05	181	89	5	c62b0a2422377ffadaab63edd538e87a06fa5017
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	ADAMTS19 NKD1 TSPEAR TMEM200C RYR3	3.15e-05	181	89	5	8e751f5d7cd2d328ec0196d874e8a507e8c4e1a9
ToppCell	Children_(3_yrs)-Epithelial-club_cell-D139\|Children_(3_yrs) / Lineage, Cell type, age group and donor	CFH PLEKHG4B CPAMD8 COLCA1 PLEKHS1	3.23e-05	182	89	5	215c303df42f13597b2c7a95cb157c6bc7aca9a1
ToppCell	Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2-Exc_L6_FEZF2_VWA2\|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	CFH ADAMTS19 SEMA5B SLIT3 RYR3	3.23e-05	182	89	5	72e65a23cd36085bc880087d3cae92395de918a1
ToppCell	Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2\|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	CFH ADAMTS19 SEMA5B SLIT3 RYR3	3.23e-05	182	89	5	05c167158815bf25d509df59ab386e1990712765
ToppCell	Adult-Mesenchymal-airway_smooth_muscle_cell-D175\|Adult / Lineage, Cell type, age group and donor	PLEKHG4B SLIT3 SCART1 MAP3K12 RYR3	3.23e-05	182	89	5	ad4d74d8b19976e1ccc3c5ba8013199338cf6fd8
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ADAMTS19 NKD1 TSPEAR TMEM200C RYR3	3.32e-05	183	89	5	612d93df03252d4d2ccdce5a9bc162cfd9172a1a
ToppCell	droplet-Kidney-KIDNEY-30m-Epithelial-Stroma____kidney_mesangial_cell\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CFH NKD1 C11orf96 SLIT3 ADCY5	3.32e-05	183	89	5	8de4b616a06be03e1cb6ae6a9ce6bf06485629d3
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ADAMTS19 NKD1 TSPEAR TMEM200C RYR3	3.32e-05	183	89	5	eb559ae3ae252d9365c24ef557dd49b78ed6d898
ToppCell	wk_20-22-Epithelial-Proximal_epithelial-Late_airway_progenitor\|wk_20-22 / Celltypes from embryonic and fetal-stage human lung	CFH CPAMD8 CELSR2 LAMA5 FBN3	3.32e-05	183	89	5	0cea883a8a79fc58abcb26b08bf5db9d3d60f7d4
ToppCell	Adult-Epithelial-club_cell-D231\|Adult / Lineage, Cell type, age group and donor	CFH PLEKHG4B CPAMD8 COLCA1 PLEKHS1	3.68e-05	187	89	5	ee59d7d3de5879738ff0b9c3ea5e4847fb48cb86
ToppCell	Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1-D150\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	PLEKHG4B CPAMD8 LAMA3 LAMA5 FBN3	3.68e-05	187	89	5	4ae7465174e0295d2c3b614b321a3b2f514dd22a
ToppCell	15-Trachea-Epithelial-Secretory_progenitor\|Trachea / Age, Tissue, Lineage and Cell class	CFH CPAMD8 NXPH4 FBN3 GGT5	3.68e-05	187	89	5	be9fce9e74b2f170a2067f1b31d802912a578329
ToppCell	LA-13._Vascular_Smooth_Muscle\|LA / Chamber and Cluster_Paper	NKD1 SLIT3 LAMA3 RYR2 RYR3	3.77e-05	188	89	5	34e1b074a3995aa46ab194eb45115d76d1a5514d
ToppCell	facs-Trachea-3m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l39\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	PPP1R3D SEMA5B C11orf96 LAMA5 RYR2	3.77e-05	188	89	5	a5e7a363fbd5ae4d9312cf6f9941413d6a5c0b4d
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	NKD1 C11orf96 SLIT3 ADCY5 RYR2	3.87e-05	189	89	5	127ad2ba3e794df8cce2eee3e4171bccb5aad51b
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	NKD1 C11orf96 SLIT3 ADCY5 RYR2	3.87e-05	189	89	5	2cfb4d12f75678d1619f4743838a0e954bd57761
ToppCell	Adult-Epithelial-club_cell\|Adult / Lineage, Cell type, age group and donor	CFH PLEKHG4B CPAMD8 COLCA1 PLEKHS1	3.97e-05	190	89	5	756bff697d30aec56c0ebfca94295f084a15bf37
ToppCell	Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)\|World / Lineage, Cell type, age group and donor	CPAMD8 CELSR2 LAMA3 LAMA5 FBN3	4.07e-05	191	89	5	d3733c8c4bda70c4390e5601fdda6188a64be944
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	NKD1 C11orf96 SLIT3 ADCY5 RYR2	4.17e-05	192	89	5	bfab13793e54de2550ee171397f7ece0625cdb4a
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	NKD1 C11orf96 SLIT3 ADCY5 RYR2	4.17e-05	192	89	5	b54b0d5b88139905521c8d5d58332e89c08d589c
ToppCell	droplet-Heart-HEART-1m-Mesenchymal-smooth_muscle_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NKD1 SEMA5B C11orf96 ADCY5 FAM241A	4.17e-05	192	89	5	eb9a0b3d32f90f8b95905c740aab21639dae5cbd
ToppCell	Epithelial-club_cell\|World / Lineage, Cell type, age group and donor	CFH PLEKHG4B CPAMD8 COLCA1 PLEKHS1	4.27e-05	193	89	5	2bdd09004fa433550958ec42ba4b06271a4aaf7c
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	NKD1 C11orf96 SLIT3 ADCY5 RYR2	4.38e-05	194	89	5	5c3b2b05d1e4f146551fe4c920263d8e6ca34de3
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	NKD1 C11orf96 SLIT3 ADCY5 RYR2	4.38e-05	194	89	5	ab9cad697f9209d2889bc02b43b502dfeb2ebfef
ToppCell	kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	CFH ADAMTS19 ARHGAP23 SLIT3 TMEM200C	4.38e-05	194	89	5	1374600957c7d7f0b05fd2c1186f521b9096d4ef
ToppCell	droplet-Liver-LIVER-NPC-1m-Endothelial-endothelial_cell_of_hepatic_sinusoid\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NKD1 ARHGAP23 C11orf96 RIPPLY3 CCDC85B	4.49e-05	195	89	5	85df110f753f58ab017018c54ee454edb4428e29
ToppCell	3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-tracheobronchial_smooth_muscle_cell-Smooth_muscle\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	NKD1 C11orf96 SLIT3 CHRD ADCY5	4.60e-05	196	89	5	cda3681f032f740cb09c64c62b9153cb62dbb5d2
ToppCell	3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-tracheobronchial_smooth_muscle_cell-Smooth_muscle-Smooth_muscle_L.2.3.0.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	NKD1 C11orf96 SLIT3 CHRD ADCY5	4.60e-05	196	89	5	b55aa507429ddce89ad4f42ab6daeca2f34fd676
ToppCell	3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-tracheobronchial_smooth_muscle_cell\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	NKD1 C11orf96 SLIT3 CHRD ADCY5	4.60e-05	196	89	5	208ddedd29e1b9ca89cbb9b527c2e193a44cada2
ToppCell	COVID-19-lung-Pericytes/_Smooth_Muscle\|COVID-19 / Disease (COVID-19 only), tissue and cell type	NKD1 C11orf96 SLIT3 ADCY5 RYR2	4.60e-05	196	89	5	754a3613340932563cd8424d775e18b93c3a1aaa
ToppCell	Bronchial-NucSeq-Stromal-Myofibroblastic-Muscle_perivascular_immune_recruiting\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	CFH C11orf96 SLIT3 ADCY5 RYR2	4.71e-05	197	89	5	cfb3dc4b401800e33c82cfc3baee69dbbd16ac8c
ToppCell	Basal_cells\|World / lung cells shred on cell class, cell subclass, sample id	CFH CELSR2 ARHGAP23 DLK2 LAMA5	4.71e-05	197	89	5	24360b660000bdfb999d58fbf4e29585a97e1785
ToppCell	Bronchial-10x5prime-Stromal-Myofibroblastic-Muscle_smooth_systemic_arterial\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	SEMA5B C11orf96 SLIT3 ADCY5 RYR2	4.71e-05	197	89	5	d1cb30ec4f3024541e9876c70bf63fe4d5c55bf1
ToppCell	COVID-19-lung-Fibroblast\|COVID-19 / Disease (COVID-19 only), tissue and cell type	CFH NKD1 SLIT3 MMP14 RYR2	4.83e-05	198	89	5	3ec01a55ade5e1627258cc3cfebb2c3207a4cb43
ToppCell	Tracheal-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_systemic_arterial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	C11orf96 CHRD LAMA5 ADCY5 RYR2	4.83e-05	198	89	5	7dd874b09c81cc512ccc1e9b65f290a5f94d736e
ToppCell	cellseq-Mesenchymal-Myocytic-Myocytic_2\|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	NKD1 C11orf96 SLIT3 CHRD ADCY5	4.83e-05	198	89	5	c7075dce915ab8387309fcb12c5f6a17d4100cda
ToppCell	Tracheal-NucSeq-Stromal-Myofibroblastic-Muscle_perivascular_immune_recruiting\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	SEMA5B C11orf96 LAMA3 CHRD GGT5	4.83e-05	198	89	5	b7e900fc0a1b3fa5e47dcc36ce6b0c3ce6bf9739
ToppCell	tumor_Lung-Fibroblasts-COL14A1+_matrix_FBs\|tumor_Lung / Location, Cell class and cell subclass	CFH C11orf96 SLIT3 MMP14 GGT5	4.83e-05	198	89	5	74f2c7ef702b25a5b99e56121229e678ed992524
ToppCell	cellseq-Mesenchymal-Myocytic-Myocytic_2-VSMC\|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	NKD1 C11orf96 SLIT3 CHRD ADCY5	4.83e-05	198	89	5	e967c601101361fc1c48dab0e5b76dc68813276e
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-Perivascular_fibroblast\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	CFH C11orf96 SLIT3 MESP2 GGT5	4.94e-05	199	89	5	dfc5c7a4a093baa7158dd8d4d29a870d9c469a3f
ToppCell	Bronchial-10x5prime-Stromal-Fibroblastic-Fibro_immune_recruiting\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	CFH SLIT3 LAMA3 ADCY5 GGT5	4.94e-05	199	89	5	0cdbedf09ec72734b86ddab3fec562e066afed92
ToppCell	10x5'v1-week_14-16-Mesenchymal_adipo-stroma\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	CFH SLIT3 PLEKHS1 MMP14 GGT5	4.94e-05	199	89	5	9b2262edbdec89166d895ab97527e0ee5f9b6010
ToppCell	Tracheal-10x5prime-Stromal-Myofibroblastic\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	NKD1 C11orf96 SLIT3 ADCY5 RYR2	4.94e-05	199	89	5	0a145172787f40d0fdaf21188d539ffaf7ece3e4
ToppCell	10x5'v1-week_14-16-Mesenchymal_adipo\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	CFH SLIT3 PLEKHS1 MMP14 GGT5	4.94e-05	199	89	5	251b3643dcd8f4645b17101bd716e66f12a20e88
ToppCell	Parenchymal-10x5prime-Stromal-Myofibroblastic\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	NKD1 C11orf96 SLIT3 CHRD ADCY5	4.94e-05	199	89	5	20f760d92c351a1dac4cc0a424c443ea03a179fe
ToppCell	Biopsy_IPF-Mesenchymal-Smooth_Muscle_cells\|Biopsy_IPF / Sample group, Lineage and Cell type	NKD1 C11orf96 SLIT3 CHRD ADCY5	4.94e-05	199	89	5	ffb871dc3d232a7bdc2d55d91b76e79883e8fa1b
ToppCell	Bronchial-10x5prime-Stromal-Myofibroblastic\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	NKD1 C11orf96 SLIT3 ADCY5 RYR2	4.94e-05	199	89	5	ad75e5e26c37a97331164d7f77235ebd9a933a44
ToppCell	Parenchymal-10x5prime-Stromal-Myofibroblastic-Muscle_smooth_pulmonary\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	NKD1 C11orf96 SLIT3 CHRD ADCY5	4.94e-05	199	89	5	7c272a1aa7f3e931ad5d20809719d85b3bce4cb0
ToppCell	Parenchyma_COVID-19-Stromal-TX-Smooth_muscle-2\|Parenchyma_COVID-19 / Sample group, Lineage and Cell type	NKD1 C11orf96 SLIT3 CHRD ADCY5	4.94e-05	199	89	5	c8bc05dece8b8a87d4a7a3e8112b924e15217de1
ToppCell	Lung_Parenchyma-Severe-Mesenchymal-Mesenchymal-Smooth_muscle-2-\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	NKD1 C11orf96 SLIT3 CHRD ADCY5	4.94e-05	199	89	5	78b245d40c1e169ff2d26907b63d732e34529c5f
ToppCell	10x5'v1-week_14-16-Mesenchymal_adipo-stroma-adipo-CAR\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	CFH SLIT3 PLEKHS1 MMP14 GGT5	4.94e-05	199	89	5	117f4f43b6c06dda553799b1063e827bce697370
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-Perivascular_fibroblast-G\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	CFH C11orf96 SLIT3 MESP2 GGT5	4.94e-05	199	89	5	c1760581c34b81d1d92c67500a1c8944e9cc6dad
ToppCell	Lung_Parenchyma-Severe-Mesenchymal-Mesenchymal-Smooth_muscle-2\|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09)	NKD1 C11orf96 SLIT3 CHRD ADCY5	4.94e-05	199	89	5	8e1e95c3a4b856415af208be6ad977e575bac189
ToppCell	Parenchymal-10x5prime-Stromal-Peri/Epineurial_-NAF_epineurial\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	ZNF512B ZNF517 SLIT3 VSIG10L CHRD	5.06e-05	200	89	5	36de49593cf6ff1c9229fcceb150c1d68658a360
ToppCell	Bronchial-NucSeq-Stromal-Myofibroblastic\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	NKD1 C11orf96 SLIT3 ADCY5 RYR2	5.06e-05	200	89	5	a66449b22b39dd6987fc2c3ed160d24564234ced
Disease	n-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase measurement	CFH NAGPA	8.40e-06	2	86	2	EFO_0801816
Disease	congenital myopathy 1A (implicated_via_orthology)	RYR2 RYR3	2.51e-05	3	86	2	DOID:3529 (implicated_via_orthology)
Disease	malignant hyperthermia (implicated_via_orthology)	RYR2 RYR3	2.51e-05	3	86	2	DOID:8545 (implicated_via_orthology)
Disease	Night blindness, congenital stationary, type 1	CACNA1F GPR179	5.44e-04	12	86	2	C3501847
Disease	Night Blindness, Congenital Stationary, Type 1A	CACNA1F GPR179	5.44e-04	12	86	2	C3495587
Disease	NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 2B (disorder)	CACNA1F GPR179	5.44e-04	12	86	2	C1864877
Disease	NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1B	CACNA1F GPR179	5.44e-04	12	86	2	C1850362
Disease	X-Linked Csnb	CACNA1F GPR179	5.44e-04	12	86	2	C3711543
Disease	NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 2A	CACNA1F GPR179	5.44e-04	12	86	2	C1848172
Disease	Cone-rod synaptic disorder, congenital nonprogressive	CACNA1F GPR179	6.41e-04	13	86	2	C4041558
Disease	Night blindness, congenital stationary	CACNA1F GPR179	1.11e-03	17	86	2	C0339535
Disease	esophagus squamous cell carcinoma (is_marker_for)	KMT2D MMP14 TERT	1.33e-03	74	86	3	DOID:3748 (is_marker_for)
Disease	pulmonary hypertension (biomarker_via_orthology)	TERT RYR2 RYR3	1.67e-03	80	86	3	DOID:6432 (biomarker_via_orthology)
Disease	beta-aminoisobutyric acid measurement	AGXT2 FBN3	2.22e-03	24	86	2	EFO_0010464
Disease	lung squamous cell carcinoma (is_implicated_in)	KMT2D TERT	2.22e-03	24	86	2	DOID:3907 (is_implicated_in)
Disease	birth weight, parental genotype effect measurement	ZNF512B NFILZ ADCY5 RAI1	2.43e-03	192	86	4	EFO_0004344, EFO_0005939

Protein segments in the cluster

Peptide	Gene	Start	Entry
VFRGPWGGSHCRDSP	AGXT2	231	Q9BYV1
RSCGKGDPADRPWAG	CCDC187	1011	A0A096LP49
CLALGEEWGPRGGPS	CCDC85B	141	Q15834
PAAGEAGGSCLRWEP	APCDD1L	21	Q8NCL9
RGDAVCTESGWRPLP	CFH	246	P08603
APEGCPWSCRLLGIG	CELSR2	106	Q9HCU4
APRGGPEHRSAWGEA	ADCY5	21	O95622
CSKRPGEGWGDPCEL	FBN3	2041	Q75N90
ALRDWMGCPSGGRPD	MMP14	501	P50281
PEPRSSDGLGVGRAW	NXPH4	51	O95158
EWIGRQRCPGGVSGP	NKD1	36	Q969G9
LGDACPRWGLHPGEL	RAI1	751	Q7Z5J4
EGHVGSRPELRPCWG	NFILZ	201	A0A5F9ZHS7
CGPRDLGWEPAVERD	RASSF1	106	Q9NS23
ALWRREPVDPAGGSG	ADAMTS19	41	Q8TE59
CVGGRGASVPWDFLP	NPAS1	16	Q99742
FPGRGGVWRVVCRDP	PNMA8A	86	Q86V59
QTECRGRWPGPNGGI	CACNA1F	296	O60840
GWTGIRCDSTCPPGR	MEGF11	556	A6BM72
RDGDRWRSASPDGGP	GIGYF1	221	O75420
WATATCGERGPGEGR	LAMA3	61	Q16787
RTQCEHPCWEGGRGP	INKA2	71	Q9NTI7
CPWESADRGGLSPGS	GPR179	1321	Q6PRD1
PPGGWAVARLEGREF	FOXK2	31	Q01167
RQRGDAGSPWGCPLC	MESP2	151	Q0VG99
GCIEPGPGHWGELSR	CCDC97	16	Q96F63
WLEAVFGTPRRAGCP	PDCD7	146	Q8N8D1
PAAGCVRGERPGWAA	PINK1	36	Q9BXM7
KARGRGCHCPGDAPW	RIPPLY3	11	P57055
LPRACWEGRITAGSP	LRRC74A	11	Q0VAA2
RCPEPDARHGWGSGS	LCA10	71	Q71F78
TGPRGAGRPCLFWDQ	KREMEN2	51	Q8NCW0
GFWGLSPSNPEGCTR	LAMA5	761	O15230
LPRAGGWAVPRGCDP	PSMB11	21	A5LHX3
CGSPPRGWSEELDER	ARHGAP12	336	Q8IWW6
ASLGPEWSQEGCRPG	FAM182B	126	Q5T319
FSCGGWIRRNPLPDG	EEF1AKMT4-ECE2	241	P0DPD8
GALSTSIPWGCRDPG	CEFIP	341	Q711Q0
ALSDSPDGRPGGFWR	KCNC1	156	P48547
QLPCGEGRPGWVRGE	COLCA1	41	Q6ZS62
REAAGTGWDPGASPR	FAM241A	26	Q8N8J7
RVEPFLRPEWSGTGG	COX11	31	Q9Y6N1
ACNEVERAPARGPGW	CPAMD8	1676	Q8IZJ3
PGGRPPRADAKCWFA	GUCY2F	441	P51841
VSGDRVGGAPGRCWP	GGT5	446	P36269
CSPDGEWRRLGRPVF	IDUA	481	P35475
GGGPSAWEACPPALR	MAP3K12	581	Q12852
APREDGGARGVWLPS	IFRD2	16	Q12894
GTGTRLAPWPGRACG	ME3	6	Q16798
APDGSCRCDPGWEGL	DLK2	41	Q6UY11
GGEPRTDCTISWGGP	ETV2	171	O00321
GDMRVGWSRPGCQPD	RYR2	1111	Q92736
RDCGVAATGLPPRVW	NEURL4	176	Q96JN8
RWSAALPCAEARGPG	TRMT44	46	Q8IYL2
GASCSWQRPPGERGS	TMEM200C	396	A6NKL6
GLWPGRPCSAGREVD	KCP	1381	Q6ZWJ8
SSVWGPPDACRGDLR	MIIP	71	Q5JXC2
FWRGPGCDELDCGPS	NAGPA	351	Q9UK23
RACLEPGGLGPRTEW	SWSAP1	181	Q6NVH7
EEPPSEGPGSCLRRW	NUAK2	581	Q9H093
LPVRCAGDWLPRGLG	ALG2	66	Q9H553
ACEAPQWGRRTRGPG	CHRD	81	Q9H2X0
DLRPRGQPGWCRLGD	C11orf96	106	Q7Z7L8
GQPGWCRLGDPRRDS	C11orf96	111	Q7Z7L8
RPGWTGPLCDQEARD	SLIT3	1356	O75094
GRICVSQWEGPPRLG	PLEKHS1	341	Q5SXH7
WAPGGDLEGCAPDTR	RNF149	81	Q8NC42
FSEPGVWGPRPCRVG	RP1L1	376	Q8IWN7
SEWGGRPQGCPGKAR	RP1L1	546	Q8IWN7
ADPEGPEGGCSLAWR	SLC27A3	56	Q5K4L6
VGWARPGCRPDVELG	RYR3	1101	Q15413
GPAEEGAREPGWCKT	SOX12	21	O15370
DGETLRPGLCALWDP	PLEKHG4B	666	Q96PX9
GPGALVSPRFERCGW	ARHGAP23	366	Q9P227
ASPRGDPGLGERDWT	TNKS1BP1	761	Q9C0C2
PGGGTERPCASAWQL	TMEM102	351	Q8N9M5
GPRPAGEWEGDRAEA	ZBTB4	206	Q9P1Z0
ARWRGPAGPEGTEDV	PPP1R3D	221	O95685
SWLGCPEEGALRVRG	SCART1	776	Q4G0T1
CPVRNVTRDGGFGPW	SEMA5B	601	Q9P283
REPGEDTEGRRAPCW	ZNF517	476	Q6ZMY9
PGRSELVEGCGWRCP	TRIM14	11	Q14142
DWPPGCRDKGARGST	ZNF512B	866	Q96KM6
PGHGTQGWEPCTDLR	TSPEAR	16	Q8WU66
PGDRSLRFRCSWPGG	VSIG10L	506	Q86VR7
GEAWLECSLRGGTPP	VSIG10L2	516	P0DP72
ERPRGDAGAEWEPLG	ZNF71	46	Q9NQZ8
DCAWLRRSPGVGCVP	TERT	516	O14746
GVRIPPSGWKCARCD	USP13	201	Q92995
TCRVAGGPGTPRLAW	TMEM25	51	Q86YD3
SPGPGSGGERWCAEV	WDR73	216	Q6P4I2
ERGETPWCSVPRGAL	ZNF662	26	Q6ZS27
GEEAPRFPHLGSGRW	KMT2D	4716	O14686